e-learning
resources
Madrid 2019
Monday, 30.09.2019
ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
No-Sedation in Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients;A Rondomized Controlled Trial
M. Abdelghany (assiut, Egypt), M. Gamal (assiut, Egypt), E. Zareef (assiut, Egypt), A. Elkarn (assiut, Egypt)
Source:
International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Session:
ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Session type:
Poster Discussion
Number:
2178
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Abdelghany (assiut, Egypt), M. Gamal (assiut, Egypt), E. Zareef (assiut, Egypt), A. Elkarn (assiut, Egypt). No-Sedation in Mechanically Ventilated Chronic Obstructive Pulmonary Disease Patients;A Rondomized Controlled Trial. 2178
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
A Comparison of Pulmonary Rehabilitation Outcomes in Interstitial Lung Disease and Chronic Obstructive Pulmonary Disease
Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Year: 2019
Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 - Pre-reading material
Year: 2020
European Respiratory Society Guideline on Long-term Home Non-Invasive Ventilation for Management of Chronic Obstructive Pulmonary Disease
Source: Guideline 2019
Year: 2019
Impact of Pulmonary Hypertension on the Response to Pulmonary Rehabilitation in Obstructive Lung Disease
Source: International Congress 2019 – The future of pulmonary rehabilitation discussed today
Year: 2019
Update on Limb Muscle Dysfunction in Chronic Obstructive Pulmonary Disease
Source: Guideline 2014
Year: 2014
Evaluation of Co-morbidities among Different Chronic Obstructive Pulmonary Disease Phenotypes
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
The implementation of a psychological support during the adaptation to Non Invasive Ventilation (NIV) in Chronic Obstructive Pulmonary Disease (COPD): a Randomized Controlled Trial
Source: International Congress 2018 – Hot topics in non-invasive ventilation
Year: 2018
Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control
Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD
Year: 2020
Risk Factor for Chronic Obstructive Pulmonary Disease in Never-Smoker Patients with Non-Cystic Fibrosis Bronchiectasis
Source: International Congress 2019 – Bronchiectasis
Year: 2019
Determinants of Airflow Limitation in Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair
Year: 2020
Nutritional Supplementation during Pulmonary Rehabilitation in Stable Chronic Obstructive Pulmonary Disease: A Systematic Review
Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases
Year: 2019
Chronic Obstructive Pulmonary Disease Exacerbations
Source: Eur Respir Rev 2009; 18: 305
Year: 2009
Study Of Risk Factors For Arrhythmias Among Chronic Obstructive Pulmonary Disease Patients Having Ischaemic Heart Disease.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Smart Watch-based Coaching with Tiotropium and Olodaterol Ameliorates Physical Activity in Chronic Obstructive Pulmonary Disease Patients
Source: International Congress 2017 – Bronchodilators and bronchoprotectors
Year: 2017
Skeletal Muscle Dysfunction in Chronic Obstructive Pulmonary Disease
Source: Guideline 1999
Year: 1999
The Impact of Multimorbidity on Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Population-Based Study
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Advance Care Planning in Patients with Chronic Obstructive Pulmonary Disease assessed for Long Term Oxygen Therapy
Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD
Year: 2018
Triple Therapy Pathways: A Multi-Country, Retrospective Observational Study in Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2019 – Management of airway diseases in primary care
Year: 2019
The Effects Of Bronchiectasis Severity On Outcomes Of Chronic Obstructive Pulmonary Disease Exacerbation
Source: International Congress 2017 – Imaging markers for COPD and asthma
Year: 2017
Program of Integrated Care for Patients with Chronic Obstructive Pulmonary Disease and Multiple Comorbidities (PIC COPD
+
): a randomised controlled trial
Source: Eur Respir J, 51 (1) 1701567; 10.1183/13993003.01567-2017
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept